Literature DB >> 9203996

Effects of hyperprolactinaemia on glucose tolerance and insulin release in male and female rats.

F M Reis1, A M Reis, C C Coimbra.   

Abstract

It has been shown that prolactin (PRL) induces glucose intolerance, hyperinsulinaemia and insulin resistance in several animal species, including rats. However, the sex differences regarding glucose homeostasis and insulin release in hyperprolactinaemic subjects have not been assessed to date. In the present study, hyperprolactinaemic (pituitary-grafted) or control (sham-operated) male and female rats were submitted to an i.v. glucose tolerance test (30 mg/100 g body weight, 30% glucose). Grafted female rats had fasting plasma glucose concentrations 26% above control (P < 0.01). After the glucose load there was a rapid and pronounced increase in plasma glucose levels in all animal groups, followed by a return to basal values within 30 min. However, the glucose concentrations in hyperprolactinaemic rats were significantly greater than those in controls at 5 min (males, P < 0.05) and 30 min (females, P < 0.05). The glucose disappearance rate was significantly increased in the grafted females compared with control (P < 0.01) and slightly increased in the grafted males. Plasma insulin concentration increased just after glucose load and returned to basal values within 5 min in all groups except for the grafted females, which had recovered their basal insulin levels at 15 min. The grafted male rats had insulin concentrations higher than those of sham-operated controls at 2 min (28.9 +/- 3.6 vs 17.3 +/- 2.1 microU/ml, P < 0.01), whereas females had plasma insulin concentrations greater than those in sham-operated controls 10 min after the glucose load (15.9 +/- 1.9 vs 10.1 +/- 1.4 microU/ml, P < 0.05). The areas under the plasma insulin concentration-time curves were also significantly increased in the hyperprolactinaemic rats and were positively correlated with plasma PRL concentrations (r = 0.613, P < 0.01). These results demonstrate that moderate chronic hyperprolactinaemia is associated with increased glucose-induced insulin release, which was altered at different times after the glucose load in grafted male and female rats, whereas fasting hyperglycaemia was observed only in grafted females, indicating a sexual dimorphism in the diabetogenic effects of PRL in rats.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203996     DOI: 10.1677/joe.0.1530423

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  12 in total

1.  Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adults.

Authors:  C D Gibson; W Karmally; D J McMahon; S L Wardlaw; J Korner
Journal:  Diabetes Obes Metab       Date:  2011-12-27       Impact factor: 6.577

2.  Effect of cabergoline on insulin sensitivity, inflammation, and carotid intima media thickness in patients with prolactinoma.

Authors:  Serap Soytac Inancli; Alper Usluogullari; Yusuf Ustu; Sedat Caner; Abbas Ali Tam; Reyhan Ersoy; Bekir Cakir
Journal:  Endocrine       Date:  2012-12-12       Impact factor: 3.633

3.  Is hyperprolactinemia associated with insulin resistance in non-obese patients with polycystic ovary syndrome?

Authors:  M Bahceci; A Tuzcu; S Bahceci; S Tuzcu
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

4.  Insulin sensitivity and hyperprolactinemia.

Authors:  A Tuzcu; M Bahceci; M Dursun; C Turgut; S Bahceci
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

5.  Evaluation of insulin sensitivity in hyperprolactinemic subjects by euglycemic hyperinsulinemic clamp technique.

Authors:  Alpaslan Tuzcu; Serkan Yalaki; Senay Arikan; Deniz Gokalp; Mithat Bahcec; Sadiye Tuzcu
Journal:  Pituitary       Date:  2009-05-01       Impact factor: 4.107

6.  Effects of lactogen resistance and GH deficiency on mouse metabolism: pancreatic hormones, adipocytokines, and expression of adiponectin and insulin receptors.

Authors:  Ramamani Arumugam; Don Fleenor; Michael Freemark
Journal:  Endocrine       Date:  2007-11-02       Impact factor: 3.633

7.  The relationship between prolactin levels and glucose homeostasis in antipsychotic-treated schizophrenic patients.

Authors:  Oliver D Howes; Shubulade Smith; Fiona P Gaughran; Stephanie A Amiel; Robin M Murray; Lyn S Pilowsky
Journal:  J Clin Psychopharmacol       Date:  2006-12       Impact factor: 3.153

8.  Effects of cabergoline on blood glucose levels in type 2 diabetic patients: A double-blind controlled clinical trial.

Authors:  Adele Bahar; Zahra Kashi; Ezzatossadat Daneshpour; Ozra Akha; Shahram Ala
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

9.  Association between serum prolactin levels and insulin resistance in non-diabetic men.

Authors:  Makoto Daimon; Aya Kamba; Hiroshi Murakami; Satoru Mizushiri; Sho Osonoi; Masato Yamaichi; Kota Matsuki; Eri Sato; Jutaro Tanabe; Shinobu Takayasu; Yuki Matsuhashi; Miyuki Yanagimachi; Ken Terui; Kazunori Kageyama; Itoyo Tokuda; Ippei Takahashi; Shigeyuki Nakaji
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

10.  PRLR regulates hepatic insulin sensitivity in mice via STAT5.

Authors:  Junjie Yu; Fei Xiao; Qian Zhang; Bin Liu; Yajie Guo; Ziquan Lv; Tingting Xia; Shanghai Chen; Kai Li; Ying Du; Feifan Guo
Journal:  Diabetes       Date:  2013-06-17       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.